Literature DB >> 16288404

Incidence of tuberculosis during highly active antiretroviral therapy in high-income and low-income countries.

Stephen D Lawn, Robin Wood.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16288404     DOI： 10.1086/498308

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  19 in total

1.  New methods for estimating the tuberculosis case detection rate in high-HIV prevalence countries: the example of Kenya.

Authors:  John Mansoer; Suzanne Scheele; Katherine Floyd; Christopher Dye; Joseph Sitienei; Brian Williams
Journal:  Bull World Health Organ       Date:  2009-03       Impact factor: 9.408

2.  High rates of tuberculosis in patients accessing HAART in rural South Africa.

Authors:  Kogieleum Naidoo; Quarraisha Abdool Karim; Ambika Bhushan; Kasavan Naidoo; Nonhlanhla Yende-Zuma; Patricia K McHunu; Janet Frohlich; Farina Karim; Michele Upfold; Paul Kocheleff; Salim S Abdool Karim
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

3.  Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program.

Authors:  Hermann Bussmann; C William Wester; Ndwapi Ndwapi; Nicolas Grundmann; Tendani Gaolathe; John Puvimanasinghe; Ava Avalos; Madisa Mine; Khumo Seipone; Max Essex; Victor Degruttola; Richard G Marlink
Journal:  AIDS       Date:  2008-11-12       Impact factor: 4.177

4.  Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.

Authors:  Sabine M Hermans; Agnes N Kiragga; Petra Schaefer; Andrew Kambugu; Andy I M Hoepelman; Yukari C Manabe
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

Review 5.  5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice - clinical sciences.

Authors:  Mark Mascolinli; Rodney Kort
Journal:  J Int AIDS Soc       Date:  2010-06-01       Impact factor: 5.396

6.  Short and Long-Term Incidence of Tuberculosis and CD4-Cell Count Dynamic on HAART in Senegal.

Authors:  Jean-François Etard; Assane Diouf; Pierre De Beaudrap; Koivugui Akoi; Ndèye Fatou Ngom-Guèye; Ibrahima Ndiaye; René Ecochard; Papa Salif Sow; Delaporte Eric
Journal:  Open AIDS J       Date:  2009-12-31

7.  Potentially preventable tuberculosis among HIV-infected persons in the era of highly active antiretroviral treatment.

Authors:  A C Pettit; G Barkanic; S Stinnette; P Rebeiro; R Blackwell; S P Raffanti; B E Shepherd; T R Sterling
Journal:  Int J Tuberc Lung Dis       Date:  2009-03       Impact factor: 2.373

8.  Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort study.

Authors:  Maxwell O Akanbi; Chad J Achenbach; Joe Feinglass; Babafemi Taiwo; Adamu Onu; Mai T Pho; Oche Agbaji; Phyllis Kanki; Robert L Murphy
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-25       Impact factor: 2.205

9.  Advances in the Diagnosis, Treatment and Control of HIV Associated Tuberculosis.

Authors:  Bruce J Kirenga; Duncan M Chanda; Catherine M Muwonge; Getnet Yimer; Francis E Adatu; Philip C Onyebujoh
Journal:  Afr J Infect Dis       Date:  2012

10.  Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database.

Authors:  S H Han; J Zhou; M P Lee; H Zhao; Y-M A Chen; N Kumarasamy; S Pujari; C Lee; S F S Omar; R Ditangco; N Phanuphak; S Kiertiburanakul; R Chaiwarith; T P Merati; E Yunihastuti; J Tanuma; V Saphonn; A H Sohn; J Y Choi
Journal:  HIV Med       Date:  2013-08-28       Impact factor: 3.180
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.